Selected research
Market Structure
Global Temazepam Capsule Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Temazepam Capsule market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Temazepam Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Temazepam Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Temazepam Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Temazepam Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Temazepam Capsule include Teva, Sun Pharma, Mylan, Mallinckrodt Pharmaceuticals, Major Pharmaceuticals and Ascend Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Temazepam Capsule market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Temazepam Capsule and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Temazepam Capsule sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Temazepam Capsule market size, projected growth trends, production technologies, key applications, and end-use industries.
Temazepam Capsule Segment by Company
Teva
Sun Pharma
Mylan
Mallinckrodt Pharmaceuticals
Major Pharmaceuticals
Ascend Laboratories
Temazepam Capsule Segment by Type
7.5mg
30mg
22.5mg
15mg
Temazepam Capsule Segment by Application
Recovery Center
Hospital
Special Clinic
Temazepam Capsule Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Temazepam Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Temazepam Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Temazepam Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Temazepam Capsule market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Temazepam Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Temazepam Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Temazepam Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 7.5mg
- 30mg
- 22.5mg
- 15mg
Applications
- Recovery Center
- Hospital
- Special Clinic
Companies covered
- Teva
- Sun Pharma
- Mylan
- Mallinckrodt Pharmaceuticals
- Major Pharmaceuticals
- Ascend Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Temazepam Capsule Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Temazepam Capsule Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Temazepam Capsule Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Temazepam Capsule Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Temazepam Capsule Market Dynamics
- 2.1 Temazepam Capsule Industry Trends
- 2.2 Temazepam Capsule Industry Drivers
- 2.3 Temazepam Capsule Industry Opportunities and Challenges
- 2.4 Temazepam Capsule Industry Restraints
3 Temazepam Capsule Market by Manufacturers
- 3.1 Global Temazepam Capsule Revenue by Manufacturers (2021-2026)
- 3.2 Global Temazepam Capsule Sales by Manufacturers (2021-2026)
- 3.3 Global Temazepam Capsule Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Temazepam Capsule Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Temazepam Capsule Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Temazepam Capsule Manufacturers, Product Type & Application
- 3.7 Global Temazepam Capsule Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Temazepam Capsule Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Temazepam Capsule Players Market Share by Revenue in 2025
- 3.8.3 2025 Temazepam Capsule Tier 1, Tier 2, and Tier 3
4 Temazepam Capsule Market by Type
- 4.1 Temazepam Capsule Type Introduction
- 4.1.1 7.5mg
- 4.1.2 30mg
- 4.1.3 22.5mg
- 4.1.4 15mg
- 4.2 Global Temazepam Capsule Sales by Type
- 4.2.1 Global Temazepam Capsule Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Temazepam Capsule Sales by Type (2021-2032)
- 4.2.3 Global Temazepam Capsule Sales Market Share by Type (2021-2032)
- 4.3 Global Temazepam Capsule Revenue by Type
- 4.3.1 Global Temazepam Capsule Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Temazepam Capsule Revenue by Type (2021-2032)
- 4.3.3 Global Temazepam Capsule Revenue Market Share by Type (2021-2032)
5 Temazepam Capsule Market by Application
- 5.1 Temazepam Capsule Application Introduction
- 5.1.1 Recovery Center
- 5.1.2 Hospital
- 5.1.3 Special Clinic
- 5.2 Global Temazepam Capsule Sales by Application
- 5.2.1 Global Temazepam Capsule Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Temazepam Capsule Sales by Application (2021-2032)
- 5.2.3 Global Temazepam Capsule Sales Market Share by Application (2021-2032)
- 5.3 Global Temazepam Capsule Revenue by Application
- 5.3.1 Global Temazepam Capsule Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Temazepam Capsule Revenue by Application (2021-2032)
- 5.3.3 Global Temazepam Capsule Revenue Market Share by Application (2021-2032)
6 Global Temazepam Capsule Sales by Region
- 6.1 Global Temazepam Capsule Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Temazepam Capsule Sales by Region (2021-2032)
- 6.2.1 Global Temazepam Capsule Sales by Region (2021-2026)
- 6.2.2 Global Temazepam Capsule Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Temazepam Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Temazepam Capsule Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Temazepam Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Temazepam Capsule Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Temazepam Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Temazepam Capsule Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Temazepam Capsule Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Temazepam Capsule Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Temazepam Capsule Revenue by Region
- 7.1 Global Temazepam Capsule Revenue by Region
- 7.1.1 Global Temazepam Capsule Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Temazepam Capsule Revenue by Region (2021-2026)
- 7.1.3 Global Temazepam Capsule Revenue by Region (2027-2032)
- 7.1.4 Global Temazepam Capsule Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Temazepam Capsule Revenue (2021-2032)
- 7.2.2 North America Temazepam Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Temazepam Capsule Revenue (2021-2032)
- 7.3.2 Europe Temazepam Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Temazepam Capsule Revenue (2021-2032)
- 7.4.2 Asia-Pacific Temazepam Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Temazepam Capsule Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Temazepam Capsule Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Teva
- 8.1.1 Teva Company Information
- 8.1.2 Teva Business Overview
- 8.1.3 Teva Temazepam Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Teva Temazepam Capsule Product Portfolio
- 8.1.5 Teva Recent Developments
- 8.2 Sun Pharma
- 8.2.1 Sun Pharma Company Information
- 8.2.2 Sun Pharma Business Overview
- 8.2.3 Sun Pharma Temazepam Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sun Pharma Temazepam Capsule Product Portfolio
- 8.2.5 Sun Pharma Recent Developments
- 8.3 Mylan
- 8.3.1 Mylan Company Information
- 8.3.2 Mylan Business Overview
- 8.3.3 Mylan Temazepam Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Mylan Temazepam Capsule Product Portfolio
- 8.3.5 Mylan Recent Developments
- 8.4 Mallinckrodt Pharmaceuticals
- 8.4.1 Mallinckrodt Pharmaceuticals Company Information
- 8.4.2 Mallinckrodt Pharmaceuticals Business Overview
- 8.4.3 Mallinckrodt Pharmaceuticals Temazepam Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Mallinckrodt Pharmaceuticals Temazepam Capsule Product Portfolio
- 8.4.5 Mallinckrodt Pharmaceuticals Recent Developments
- 8.5 Major Pharmaceuticals
- 8.5.1 Major Pharmaceuticals Company Information
- 8.5.2 Major Pharmaceuticals Business Overview
- 8.5.3 Major Pharmaceuticals Temazepam Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Major Pharmaceuticals Temazepam Capsule Product Portfolio
- 8.5.5 Major Pharmaceuticals Recent Developments
- 8.6 Ascend Laboratories
- 8.6.1 Ascend Laboratories Company Information
- 8.6.2 Ascend Laboratories Business Overview
- 8.6.3 Ascend Laboratories Temazepam Capsule Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Ascend Laboratories Temazepam Capsule Product Portfolio
- 8.6.5 Ascend Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Temazepam Capsule Value Chain Analysis
- 9.1.1 Temazepam Capsule Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Temazepam Capsule Production Mode & Process
- 9.2 Temazepam Capsule Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Temazepam Capsule Distributors
- 9.2.3 Temazepam Capsule Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst